Miltenyi Biotec

@miltenyibiotec

Empowering cell research and therapy with innovative products for researchers and clinicians. Stay connected for company news, scientific resources and events.

Global
Vrijeme pridruživanja: svibanj 2009.

Medijski sadržaj

  1. 31. sij

    We'd hate to miss out on all the fun... Get you cells who can do it all 😉

  2. 28. sij

    is in full swing! Stop by our booth #434 to discuss your bioassays or identify the products that match your workflow the best.

  3. 13. sij

    Don’t miss your chance to sign up for our MACSQuant® User Day at the Science Gallery in London, 25 Feb. Experts within cell analysis in immuno-oncology, cell and gene therapy, and more will join us. Register for free today!

  4. 24. pro 2019.

    🎄 Dashing through the flow, 🎁 In a gentle way, 🎅 Through the channel we go, 🤶 Fluorescing all the way, 🔔 Ohhhh jingle cells, jingle cells … ☃️ Merry Christmas to you and your cells! ❄️

  5. 6. pro 2019.

    This is how the autoMACS® Pro looks like in our lab! We are curious about yours 🤔. Share a quick pic in the comments to see if you have the best looking lab!

  6. 3. pro 2019.
  7. 29. stu 2019.

    Proud to see the MACSQuant® Tyto® Cell Sorter is helping Immatics, a clinical-stage biopharmaceutical company, with their development of immunotherapies.

  8. 28. stu 2019.

    *Gobble, gobble* Be thankful for your happy cells! Wishing all of our US customers a happy ! 🦃🇺🇸

  9. 22. stu 2019.

    Want to analyze complex 3D micro-environments in tumors? Discover the possibilities of light sheet microscopy for immuno-oncology here:

  10. 20. stu 2019.

    CAR-T cells and more: ATMP-Workshop “Future in Medicine – Innovative Cell and Gene Therapies” Novel technologies, regulatory aspects, manufacturing and reimbursement. Presentations and discussions of leading European experts. Join us in Brussels, Dec 3:

  11. 19. stu 2019.

    Scalable & automated - Learn more about our analytical assays for cell therapy. Come to the talk of Tatjana Holzer at the CAR-TCR Analytical Development Summit in Boston. More information here:

  12. 5. stu 2019.

    Stop by booth B3 at Drug Discovery 2019 in Liverpool and unlock your high-throughput potential with our automated cell isolation and analysis solutions!

  13. 31. lis 2019.

    We’ve put a spell on our happy cells! Wishing you and your cells a fang-tastic Halloween from Miltenyi Biotec. 🎃👻

  14. 30. lis 2019.

    Only one more week till Drug Discovery in Liverpool! Don’t miss our podium presentation “Automation meets cell separation: primary cells for drug discovery assays” on Tuesday, November 5, 2019, 12:00 p.m., room 3A:

  15. 21. lis 2019.

    Attending IUIS in Beijing? Meet our immunology application and instrument experts at our booth!

  16. 17. lis 2019.

    Analysis of CAR T cells is now proving to be a bottleneck for clinical production. Read this interview with Dr Andree Salz as he discusses this bottleneck and what can be implemented to streamline this important analysis:

  17. 16. lis 2019.

    The CliniMACS Prodigy® Adherent Cell Culture System meets the demands for automated, GMP-compliant, and scalable manufacturing of different adherent cell types, such as PSCs, dopaminergic progenitors, and MSCs in a closed system. Learn more:

  18. 16. lis 2019.

    Are you looking to increase reproducibility of your cell culture results? Watch the whole video to find out how:

  19. 14. lis 2019.

    Save the date for our UK MacsQuant User Day. On February 25, 2020, experts within cell analysis will join us at the Science Gallery London for an event full of talks, networking and knowledge sharing. Join us, register for free today:

  20. 4. lis 2019.

    Do you want to know more about improving consistency of CAR T cells? Read this interview with Nadine Mockel-Tenbrinck about the considerations for creating consistent clinical-grade CAR T cells with Miltenyi Biotec products and technologies:

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·